Seasonal allergic rhinitis
Therapeutic area
Pulmonology
Rare disease
No
- Definition
- Allergic rhinitis caused by outdoor allergens.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Seasonal allergic rhinitis
- Therapeutic area
- Pulmonology
- seasonal allergic rhinitis
- hay fever
- seasonal allergic rhinitis
- Disease mechanisms
- Inflammatory
- Severity
- Mild
- Immunology
- Pulmonology
- MONDO ID
- MONDO:0005324
- Parent condition
- MONDO:0011786
Related records
Broader conditions (17)
- Allergic disease
- Allergic respiratory disease
- Allergic rhinitis
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Hypersensitivity reaction disease
- Immune system disorder
- Inflammatory disease
- Mucositis
- Nasal cavity disorder
- Nasal disorder
- Otorhinolaryngologic disease
- Respiratory system disorder
- Rhinitis
- Upper respiratory tract disorder
Trials (233)
- 4"S" - Seasonal Symptoms Suppression Study
- A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
- A Clinical Study Evaluating the Efficacy and Safety of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
- A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
- A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis
- A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine
- A Phase III Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis
- A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions
- A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
- A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber
- A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis
- A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis
- A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)
- A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)
- A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies
- A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
- A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis
- A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis
- A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic Rhinitis
- A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis
Approved drugs (41)
- Atropine sulfate
- Azelastine hydrochloride
- Beclomethasone dipropionate
- Brompheniramine maleate
- Budesonide
- Camphor
- Carbinoxamine maleate
- Cetirizine hydrochloride
- Chlorpheniramine maleate
- Ciclesonide
- Clemastine fumarate
- Cyproheptadine hydrochloride
- Desloratadine
- Dexamethasone
- Dexamethasone sodium phosphate
- Dexbrompheniramine maleate
- Dexchlorpheniramine maleate
- Diphenhydramine hydrochloride
- Ephedrine hydrochloride
- Epinephrine
Drugs in development (34)
- Albuterol Phase 3
- Asapiprant Phase 2
- Atropine Phase 2
- Azelastine Phase 3
- Bepotastine Phase 2
- Bifidobacterium SPP. Phase 3
- Bilastine Phase 3
- Cetirizine Phase 3
- Chlorpheniramine Phase 2
- Epinastine Phase 3
- Fexofenadine Phase 3
- GSK-1004723 Phase 2
- GSK-256066 Phase 2
- Histamine Phase 2
- Imatinib Phase 1
- IRL-201104 Phase 2
- JNJ-49095397 Phase 2
- Lactobacillus acidophilus Phase 3
- Levocabastine Phase 2
- Levocetirizine Phase 3
Other linked drugs (8)
- Acetaminophen
- Bromodiphenhydramine
- Dexbrompheniramine
- Dextromethorphan hydrobromide
- Guaifenesin
- Oxatomide
- Pheniramine
- Triprolidine